-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
Inhibikase Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2020 to 2024.
- Inhibikase Therapeutics, Inc. Operating Margin for the quarter ending March 31, 2024 was -10.3 K %, a 19.8% increase year-over-year.
- Inhibikase Therapeutics, Inc. annual Operating Margin for 2023 was -7.71 K %, a 47.5% increase from 2022.
- Inhibikase Therapeutics, Inc. annual Operating Margin for 2022 was -14.7 K %, a 2984% decline from 2021.
- Inhibikase Therapeutics, Inc. annual Operating Margin for 2021 was -476 %, a 18% decline from 2020.
Operating Margin, Quarterly (% [USD])
Operating Margin, YoY Quarterly Growth (%)